海普瑞(002399) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was CNY 1,373,251,921.93, representing a 5.55% increase compared to CNY 1,301,021,684.04 in the same period last year[6]. - Net profit attributable to shareholders was CNY 155,040,262.39, a significant increase of 133.00% from CNY 66,540,023.25 year-on-year[6]. - The net profit after deducting non-recurring gains and losses reached CNY 157,052,354.18, marking a 253.00% increase from CNY 44,491,211.83 in the previous year[6]. - Basic earnings per share rose to CNY 0.1057, reflecting a 133.33% increase from CNY 0.0453 in the previous year[6]. - The net profit for the current period is CNY 154,597,836.94, compared to CNY 65,948,644.12 in the previous period, representing an increase of approximately 134%[36]. - The total comprehensive income for the current period is CNY 150,135,056.48, up from CNY 61,856,551.06 in the previous period, indicating a growth of about 143%[36]. Cash Flow and Liquidity - The net cash flow from operating activities improved to CNY 880,453,882.15, a 511.47% increase compared to a negative cash flow of CNY -213,979,198.80 in the same quarter last year[6]. - Cash and cash equivalents increased to CNY 2,225,125,933.99 from CNY 1,851,642,224.58, a growth of approximately 20.2%[27]. - The cash and cash equivalents at the end of the period reached CNY 2,108,383,601.96, compared to CNY 1,753,147,431.84 at the end of the previous period, marking an increase of approximately 20%[43]. - The company reported cash inflows from investment activities of CNY 441,112,963.21, down from CNY 1,206,613,179.47 in the previous period, reflecting a decrease of about 63%[40]. - The company’s cash outflows from financing activities totaled CNY 1,506,667,399.54, down from CNY 1,723,828,354.57 in the previous period, reflecting a decrease of about 13%[43]. - The company received CNY 826,834,358.22 in cash from borrowings during the current period, compared to CNY 1,517,257,215.11 in the previous period, indicating a decrease of approximately 45%[43]. Operating Costs and Expenses - Total operating costs decreased to CNY 1,184,463,117.86 from CNY 1,239,337,824.93, a reduction of about 4.4%[34]. - The company incurred total operating expenses of CNY 358,344,170.74, a decrease from CNY 1,656,590,949.14 in the previous period, indicating a reduction of approximately 78%[40]. - The company faced a notable increase in other expenses, primarily due to a telecom fraud incident involving its subsidiary Techdow Pharma Italy S.R.L., resulting in an expense of CNY 15,559,523.79[12]. Research and Development - The company's R&D expenses increased by 33.11% to CNY 35,294,968.25, compared to CNY 26,514,765.57 in the same period last year[12]. - Research and development expenses rose to CNY 35,294,968.25 from CNY 26,514,765.57, an increase of approximately 33.1%[34]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 28,328[16]. - Shenzhen Le Ren Technology Co., Ltd. holds 32.31% of shares, totaling 474,029,899 shares[16]. - Xiamen Jintian Investment Partnership (Limited Partnership) holds 27.81% of shares, totaling 408,041,280 shares[16]. - HKSCC NOMINEES LIMITED holds 15.00% of shares, totaling 220,036,980 shares[16]. - The company has a total of 46,425,600 shares held by Xiamen Water Dripping Stone Investment Partnership (Limited Partnership)[20]. - The company has a total of 40,320,000 shares held by Xiamen Feilai Stone Investment Co., Ltd.[20]. Fraud Incident - The company suffered a telecom fraud involving approximately €11.7 million, impacting net profit by RMB 15.56 million[21]. - The actual controller, Li Li, provided an advance payment of RMB 89,809,600 to safeguard the company's interests[21]. - The company has initiated an independent third-party investigation regarding the fraud incident[21]. Asset and Liability Overview - Total assets at the end of the reporting period were CNY 18,874,970,670.54, a decrease of 1.71% from CNY 19,203,415,131.24 at the end of the previous year[6]. - Total liabilities decreased to CNY 6,736,457,897.24 from CNY 7,215,037,414.42, a reduction of approximately 6.6%[30]. - Shareholders' equity increased to CNY 12,138,512,773.30 from CNY 11,988,377,716.82, reflecting a growth of about 1.3%[33]. - Inventory decreased to CNY 6,341,627,515.17 from CNY 6,654,110,787.81, a decline of about 4.7%[27]. Other Financial Metrics - The company reported a significant increase in fair value gains of 161.07%, amounting to CNY 27,621,985.05, compared to CNY 10,580,213.43 in the previous year[12]. - The company experienced a substantial increase in operating profit, which reached CNY 196,847,737.66, a 167.28% increase from CNY 73,649,081.61 year-on-year[12]. - Net loss from investments was CNY -61,890,173.43, worsening from CNY -13,710,428.46 in the previous year[34]. - Gross profit margin improved, with operating costs at CNY 899,550,310.44 compared to CNY 846,991,799.17, indicating a more efficient cost structure[34].